Description
Research Areas
- TREK-1 potassium channel inhibition
- Antidepressant-like signaling research
- BDNF upregulation and neuroplasticity
- Novel non-SSRI depression mechanism studies
Price range: $65.00 through $109.00
Spadin analog targeting TREK-1 (TRAAK/TWIK) potassium channels. Researched for antidepressant-like effects and neuroplasticity through BDNF upregulation without classical SSRI mechanisms.
Phorm Labs
Research Areas
| Weight | .20 lbs |
|---|---|
| Dimensions | 7 × 4 × 3 in |
| Please Select | 5mg, 10mg |
Reviews
There are no reviews yet.